INIS
patients
100%
nervous system diseases
78%
colombia
69%
hospitals
37%
adults
36%
psychological behavior
35%
symptoms
34%
populations
32%
interventions
32%
risks
28%
reviews
26%
brain
25%
adolescents
25%
diseases
22%
assessments
22%
latin america
21%
control
21%
data
18%
covid-19
18%
levels
17%
people
16%
communities
16%
tools
15%
comparative evaluations
14%
income
13%
universities
13%
surveys
12%
aging
12%
units
11%
children
10%
alcohols
10%
malnutrition
10%
information
10%
implementation
10%
cost
9%
quality of life
9%
screening
8%
resources
7%
values
7%
sex
7%
education
7%
barriers
7%
multivariate analysis
6%
genetics
6%
management
6%
evaluation
6%
women
6%
classification
6%
emergencies
6%
interactions
6%
machine learning
6%
dimensions
6%
pathology
6%
mortality
5%
health services
5%
atrophy
5%
biological markers
5%
females
5%
decision making
5%
modeling
5%
performance
5%
datasets
5%
dynamics
5%
monitoring
5%
pain
5%
space
5%
workers
5%
legal aspects
5%
accuracy
5%
Keyphrases
Colombia
65%
Frontotemporal Dementia
38%
Colombians
26%
Dementia
22%
Latin America (LATAM)
21%
Neurodegeneration
21%
Mental Health
18%
Alzheimer's Disease
15%
University Hospital
13%
COVID-19
13%
Schadenfreude
12%
Healthy Controls
12%
Older Adults
12%
Empathy
11%
Primary Care
11%
Functional Decline
10%
COVID-19 Pandemic
10%
Social Cognition
10%
Health Systems
10%
Delirium
10%
Brain Health
9%
Quality of Life
9%
Mental Health Care
8%
Risk Factors
8%
National Mental Health Survey
8%
Neurocognitive
8%
Neuropsychiatric Symptoms
7%
Neurocognitive Disorders
7%
Latin American Countries
7%
Young People
6%
Electroencephalography
6%
Armed Conflict
6%
Neurodegenerative Diseases
6%
Multicentric
6%
Comorbidity
6%
Malnutrition
6%
Mental Health Problems
6%
Social Emotions
6%
Multimodal Neuroimaging
6%
High Complexity
6%
Hospitalization
5%
Anxiety Symptoms
5%
Health Professionals
5%
Depression Diagnosis
5%
Frontotemporal Lobar Degeneration
5%
Low-middle Income Countries
5%
Bogota Colombia
5%
Dementia Research
5%
Healthy Aging
5%
Caribbean Countries
5%
Emotional Faces
5%
Cluster Randomized Trial
5%
Nonagenarians
5%
Centenarians
5%
Huntington's Disease
5%
Confusional Syndrome
5%
Cost-effectiveness
5%
Adolescent Offenders
5%